EyePoint Pharmaceuticals Ownership 2024 | Who Owns EyePoint Pharmaceuticals Now?
Institutional Ownership
110.38%
Insider Ownership
1.42%
Retail Ownership
-11.79%
Institutional Holders
157.00
EyePoint Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 15.73% | 4.18% | 8,325,000 | 1,431,765 | 20.77% | 72,427,500 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.78% | 1.65% | 5,175,823 | 1,411,935 | 37.51% | 45,029,660 | Jun 30, 2024 |
| BLACKROCK INC. | 7.12% | 0.00% | 3,764,881 | 977,522 | 35.07% | 32,754,465 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 6.90% | 0.01% | 3,649,649 | 260,412 | 7.68% | 31,751,948 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.79% | 0.06% | 3,591,420 | -1,164,879 | -24.49% | 31,245,354 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.24% | 0.00% | 2,774,454 | 378,226 | 15.78% | 24,137,751 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.73% | 0.00% | 2,502,371 | 36,556 | 1.48% | 21,771,000 | Jun 30, 2024 |
| MORGAN STANLEY | 4.26% | 0.00% | 2,252,797 | 910,682 | 67.85% | 19,599,338 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 3.92% | 0.01% | 2,071,563 | 466,800 | 29.09% | 18,023,000 | Jun 30, 2024 |
| ESSEX WOODLANDS MANAGEMENT, INC. | 2.93% | 4.40% | 1,551,521 | - | - | 13,498,233 | Jun 30, 2024 |
| STATE STREET CORP | 2.31% | 0.00% | 1,219,729 | 187,157 | 18.13% | 10,611,642,000 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 2.07% | 1.50% | 1,093,503 | - | - | 9,513,476 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 2.03% | 0.11% | 1,072,577 | 443,181 | 70.41% | 9,331,420 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.95% | 0.00% | 1,032,357 | 199,720 | 23.99% | 8,983,004 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 1.74% | 0.84% | 922,335 | 922,335 | 100.00% | 8,024,315 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 1.74% | 0.00% | 921,919 | 248,571 | 36.92% | 8,020,699 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1.66% | 0.13% | 877,790 | 298,196 | 51.45% | 7,636,773 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.50% | 0.00% | 791,508 | -47,970 | -5.71% | 6,886,119 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 1.42% | 0.10% | 749,400 | 666,800 | 807.26% | 6,519,780 | Jun 30, 2024 |
| FINEPOINT CAPITAL LP | 1.34% | 1.75% | 707,404 | 50,804 | 7.74% | 6,154,415 | Jun 30, 2024 |
EyePoint Pharmaceuticals's largest institutional shareholder is CORMORANT ASSET MANAGEMENT, LP, holding 15.73% of the company's total share outstanding, currently valued at $72.43M. The top 10 institutional shareholders own together 67.39% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ESSEX WOODLANDS MANAGEMENT, INC. | 2.93% | 4.40% | 1,551,521 | - | - | 13,498,233 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 15.73% | 4.18% | 8,325,000 | 1,431,765 | 20.77% | 72,427,500 | Jun 30, 2024 |
| ORACLE INVESTMENT MANAGEMENT INC | 0.44% | 1.88% | 231,857 | -230,000 | -49.80% | 2,017,156 | Jun 30, 2024 |
| FINEPOINT CAPITAL LP | 1.34% | 1.75% | 707,404 | 50,804 | 7.74% | 6,154,415 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.78% | 1.65% | 5,175,823 | 1,411,935 | 37.51% | 45,029,660 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 2.07% | 1.50% | 1,093,503 | - | - | 9,513,476 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 1.74% | 0.84% | 922,335 | 922,335 | 100.00% | 8,024,315 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.07% | 0.41% | 37,838 | 37,838 | 100.00% | 329,191 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.09% | 0.23% | 49,905 | 38,126 | 323.68% | 434,174 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.19% | 0.21% | 100,000 | -147,968 | -59.67% | 870,000 | Jun 30, 2024 |
| MYDA ADVISORS LLC | 0.19% | 0.19% | 100,000 | -15,000 | -13.04% | 870,000 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.19% | 0.17% | 101,500 | 50,000 | 97.09% | 883,050 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.21% | 0.13% | 640,274 | 50,628 | 8.59% | 5,570,384 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1.66% | 0.13% | 877,790 | 298,196 | 51.45% | 7,636,773 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 0.55% | 0.13% | 292,926 | 122,055 | 71.43% | 2,548,456 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 2.03% | 0.11% | 1,072,577 | 443,181 | 70.41% | 9,331,420 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 1.42% | 0.10% | 749,400 | 666,800 | 807.26% | 6,519,780 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 0.09% | 0.10% | 50,000 | 50,000 | 100.00% | 435,000 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.38% | 0.07% | 201,332 | 201,332 | 100.00% | 1,751,588 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.08% | 0.07% | 42,538 | -107,281 | -71.61% | 370,081 | Jun 30, 2024 |
The largest EyePoint Pharmaceuticals shareholder by % of total assets is ESSEX WOODLANDS MANAGEMENT, INC.. The company owns 1.55M shares of EyePoint Pharmaceuticals (EYPT), representing 4.40% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 15.73% | 4.18% | 8,325,000 | 1,431,765 | 20.77% | 72,427,500 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.78% | 1.65% | 5,175,823 | 1,411,935 | 37.51% | 45,029,660 | Jun 30, 2024 |
| BLACKROCK INC. | 7.12% | 0.00% | 3,764,881 | 977,522 | 35.07% | 32,754,465 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 1.74% | 0.84% | 922,335 | 922,335 | 100.00% | 8,024,315 | Jun 30, 2024 |
| MORGAN STANLEY | 4.26% | 0.00% | 2,252,797 | 910,682 | 67.85% | 19,599,338 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 1.42% | 0.10% | 749,400 | 666,800 | 807.26% | 6,519,780 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.19% | 0.01% | 630,769 | 630,769 | 100.00% | 5,487,687 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.13% | 0.01% | 600,402 | 495,512 | 472.41% | 5,223,497 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 3.92% | 0.01% | 2,071,563 | 466,800 | 29.09% | 18,023,000 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 2.03% | 0.11% | 1,072,577 | 443,181 | 70.41% | 9,331,420 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.90% | 0.03% | 476,250 | 425,717 | 842.45% | 4,143,377 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.24% | 0.00% | 2,774,454 | 378,226 | 15.78% | 24,137,751 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1.66% | 0.13% | 877,790 | 298,196 | 51.45% | 7,636,773 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 6.90% | 0.01% | 3,649,649 | 260,412 | 7.68% | 31,751,948 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 1.74% | 0.00% | 921,919 | 248,571 | 36.92% | 8,020,699 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.38% | 0.07% | 201,332 | 201,332 | 100.00% | 1,751,588 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.95% | 0.00% | 1,032,357 | 199,720 | 23.99% | 8,983,004 | Jun 30, 2024 |
| STATE STREET CORP | 2.31% | 0.00% | 1,219,729 | 187,157 | 18.13% | 10,611,642,000 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.71% | 0.01% | 373,974 | 187,016 | 100.03% | 3,253,574 | Jun 30, 2024 |
| HAP TRADING, LLC | 0.46% | - | 245,000 | 145,000 | 145.00% | 25 | Jun 30, 2024 |
As of Jun 30 2024, EyePoint Pharmaceuticals's largest institutional buyer is CORMORANT ASSET MANAGEMENT, LP. The company purchased 1.43M stocks of EYPT, valued at $72.43M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1.10% | 0.00% | 580,716 | -1,465,722 | -71.62% | 5,052,229 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.79% | 0.06% | 3,591,420 | -1,164,879 | -24.49% | 31,245,354 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -938,591 | -100.00% | - | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | - | - | - | -585,447 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -479,682 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -388,955 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.55% | 0.01% | 290,212 | -352,964 | -54.88% | 2,524,844,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.36% | 0.00% | 189,903 | -266,723 | -58.41% | 1,652,156 | Jun 30, 2024 |
| VR ADVISER, LLC | - | - | - | -250,000 | -100.00% | - | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | - | - | - | -242,580 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | 0.03% | - | 13,697 | -238,896 | -94.58% | 119,165 | Jun 30, 2024 |
| ORACLE INVESTMENT MANAGEMENT INC | 0.44% | 1.88% | 231,857 | -230,000 | -49.80% | 2,017,156 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -206,500 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.20% | 0.00% | 633,519 | -202,203 | -24.20% | 5,511,615 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -186,300 | -100.00% | - | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.24% | 0.00% | 125,122 | -181,084 | -59.14% | 1,088,561 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.19% | 0.21% | 100,000 | -147,968 | -59.67% | 870,000 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -147,265 | -100.00% | - | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -137,000 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -136,700 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, EyePoint Pharmaceuticals's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -1.47M shares of EYPT, valued at $5.05M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | 1.74% | 0.84% | 922,335 | 922,335 | 100.00% | 8,024,315 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.38% | 0.07% | 201,332 | 201,332 | 100.00% | 1,751,588 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.22% | 0.00% | 116,195 | 116,195 | 100.00% | 1,010,897 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.20% | 0.00% | 107,756 | 107,756 | 100.00% | 937,478 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.19% | 0.01% | 101,772 | 101,772 | 100.00% | 885,415 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.14% | 0.00% | 76,288 | 76,288 | 100.00% | 664,000 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 0.09% | 0.10% | 50,000 | 50,000 | 100.00% | 435,000 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.07% | 0.41% | 37,838 | 37,838 | 100.00% | 329,191 | Jun 30, 2024 |
| MYDA ADVISORS LLC | 0.06% | 0.06% | 30,000 | 30,000 | 100.00% | 261,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 26,899 | 26,899 | 100.00% | 234,021 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.04% | 0.03% | 19,800 | 19,800 | 100.00% | 172,260 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.04% | 0.00% | 19,785 | 19,785 | 100.00% | 172,130 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 19,524 | 19,524 | 100.00% | 169,859 | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | 0.03% | 0.00% | 14,600 | 14,600 | 100.00% | 127,020 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.03% | 0.01% | 14,363 | 14,363 | 100.00% | 125,000 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.03% | 0.00% | 13,561 | 13,561 | 100.00% | 117,981 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.03% | 0.02% | 13,471 | 13,471 | 100.00% | 117,198 | Jun 30, 2024 |
| GREENWICH WEALTH MANAGEMENT LLC | 0.02% | 0.01% | 10,800 | 10,800 | 100.00% | 94,000 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.02% | 0.00% | 10,000 | 10,000 | 100.00% | 87,000 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | - | 235 | 235 | 100.00% | 2,045 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.00% | 151 | 151 | 100.00% | 1,314 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 36 | 36 | 100.00% | 313 | Jun 30, 2024 |
EyePoint Pharmaceuticals's largest new institutional shareholder by number of shares is TCG CROSSOVER MANAGEMENT, LLC, purchased 922.34K shares, valued at $8.02M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -938,591 | -100.00% | - | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | - | - | - | -585,447 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -479,682 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -388,955 | -100.00% | - | Jun 30, 2024 |
| VR ADVISER, LLC | - | - | - | -250,000 | -100.00% | - | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | - | - | - | -242,580 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -206,500 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -186,300 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -147,265 | -100.00% | - | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -137,000 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -136,700 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -134,000 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -99,765 | -100.00% | - | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | - | - | - | -92,340 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -90,000 | -100.00% | - | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -86,357 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -43,761 | -100.00% | - | Jun 30, 2024 |
| LEGACY CAPITAL GROUP CALIFORNIA, INC. | - | - | - | -33,832 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -33,036 | -100.00% | - | Jun 30, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | - | - | - | -32,052 | -100.00% | - | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -25,550 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | - | - | - | -23,896 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -22,044 | -100.00% | - | Jun 30, 2024 |
| ALGERT GLOBAL LLC | - | - | - | -20,760 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -18,378 | -100.00% | - | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -18,040 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -11,639 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -11,130 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -10,121 | -100.00% | - | Jun 30, 2024 |
| TOTH FINANCIAL ADVISORY CORP | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -3,930 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,974 | -100.00% | - | Jun 30, 2024 |
| KBC GROUP NV | - | - | - | -1,127 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -316 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -258 | -100.00% | - | Jun 30, 2024 |
| GENEOS WEALTH MANAGEMENT INC. | - | - | - | -116 | -100.00% | - | Jun 30, 2024 |
| BELLEVUE ASSET MANAGEMENT, LLC | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -28 | -100.00% | - | Jun 30, 2024 |
| CWM, LLC | - | - | - | -26 | -100.00% | - | Jun 30, 2024 |
EyePoint Pharmaceuticals's largest sold out institutional shareholder by shares sold is RA CAPITAL MANAGEMENT, L.P., sold -0.94M shares, valued at -, as of undefined.
EyePoint Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 0.70% | 5,923,300 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.29% | 2,452,933 | 198,400 | 8.80% | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.28% | 579,249 | 579,249 | - | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.26% | 637,588 | 119,668 | 23.11% | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.24% | 1,218,598 | -9,073 | -0.74% | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.24% | 570,200 | - | - | Mar 28, 2024 |
| Collaborative Investment Series Trust | 0.13% | 20,166 | - | - | Mar 31, 2024 |
| PUTNAM GLOBAL HEALTH CARE FUND | 0.12% | 204,336 | - | - | Feb 29, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.10% | 367,572 | -400 | -0.11% | Mar 31, 2024 |
| ALGER FUNDS | 0.07% | 72,100 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.05% | 412,911 | -400 | -0.10% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 21,612 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 54,100 | -18,900 | -25.89% | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 122,660 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 11,389 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 170,599 | - | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.01% | 61,623 | 61,623 | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 65,360 | 15,495 | 31.07% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.01% | 31,800 | 31,800 | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,397 | 1,228 | 29.46% | Mar 31, 2024 |
| NEXPOINT FUNDS I | 0.01% | 33,933 | - | - | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 27,438 | 434 | 1.61% | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 67,845 | - | - | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,143,168 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.01% | 20,183 | 20,183 | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.01% | 64,078 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 2,039,373 | -272,148 | -11.77% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 227,100 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 690 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 5,656 | 5,656 | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 498,510 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 69,888 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.00% | 5,600 | 5,600 | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,461 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 78,410 | 6,862 | 9.59% | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 5,064 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 342,765 | 111,550 | 48.25% | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 125,377 | 125,377 | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,719 | 1,136 | 43.98% | Mar 31, 2024 |
| FundVantage Trust | 0.00% | 21,246 | 14,577 | 218.58% | Mar 28, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 356,978 | - | - | Dec 31, 2023 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 36,241 | - | - | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 15,959 | 15,959 | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 13,054 | - | - | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 57,555 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 11,951 | 11,726 | 5211.56% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 524 | - | - | Apr 30, 2021 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 29,218 | 2,437 | 9.10% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 17,504 | 17,504 | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,065 | 1,440 | 230.40% | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 18,404 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS SECURITIES TRUST | 0.00% | 22,600 | 22,600 | - | Feb 29, 2024 |
| Meeder Funds | 0.00% | 2,837 | - | - | Mar 31, 2024 |
| PUTNAM VARIABLE TRUST | 0.00% | 20,664 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 17,020 | -2,300 | -11.90% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 12,098 | -198 | -1.61% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 159,932 | 159,303 | 25326.39% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 38,474 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 11,862 | 925 | 8.46% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 14,600 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,684 | 421 | 33.33% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 79,824 | -17,774 | -18.21% | Jan 31, 2024 |
| Global X Funds | 0.00% | 14,702 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 44,705 | - | - | Mar 28, 2024 |
| GPS Funds I | 0.00% | 1,663 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 75,000 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 387 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 13,500 | 4,400 | 48.35% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 1,901 | 1,901 | - | Mar 28, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 12,053 | - | - | Jan 31, 2024 |
| JPMorgan Trust I | 0.00% | 228,391 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 10,150 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 165,423 | - | - | Mar 31, 2024 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 76,701 | -15,390 | -16.71% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 16,343 | 4,582 | 38.96% | Mar 28, 2024 |
| EQ ADVISORS TRUST | 0.00% | 125,986 | 9,591 | 8.24% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 3,000 | - | - | Mar 28, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 441,993 | 441,993 | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 1,023 | -2,526 | -71.17% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 34,122 | -8,956 | -20.79% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 1,375,058 | 295,384 | 27.36% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 85,262 | 72,300 | 557.78% | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 6,176 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 9,995 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 4,856 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 9,862 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 119,914 | 15,101 | 14.41% | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 63,657 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 118,858 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 239 | - | - | Dec 31, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 4,550 | 2,776 | 156.48% | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,500 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,300 | 400 | 44.44% | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 5,747 | 2,435 | 73.52% | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 5,738 | 1,552 | 37.08% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 10,251 | 159 | 1.58% | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 83,400 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 7,564 | 4,176 | 123.26% | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 91,958 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 118 | - | - | Dec 31, 2023 |
EyePoint Pharmaceuticals's largest mutual fund holder by % of total assets is "FRANKLIN STRATEGIC SERIES", owning 5.92M shares, compromising 0.70% of its total assets.
EyePoint Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 157 | -10.29% |
| 31 Mar, 24 | 175 | 12.90% |
| 31 Dec, 23 | 155 | 42.20% |
| 30 Sep, 23 | 109 | 26.74% |
| 30 Jun, 23 | 86 | 22.86% |
| 31 Mar, 23 | 70 | -9.09% |
| 31 Dec, 22 | 77 | -10.47% |
| 30 Sep, 22 | 86 | 4.88% |
| 30 Jun, 22 | 82 | -3.53% |
| 31 Mar, 22 | 85 | -7.61% |
| 31 Dec, 21 | 92 | 35.29% |
| 30 Sep, 21 | 68 | 4.62% |
| 30 Jun, 21 | 65 | 3.17% |
| 31 Mar, 21 | 63 | 90.91% |
| 31 Dec, 20 | 33 | - |
As of 30 Jun 24, 157 institutions are holding EyePoint Pharmaceuticals's shares, representing a decrease of -10.29% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 58,402,790 | 6.20% |
| 31 Mar, 24 | 54,991,981 | 11.00% |
| 31 Dec, 23 | 49,541,998 | 47.02% |
| 30 Sep, 23 | 33,696,819 | 6.73% |
| 30 Jun, 23 | 31,573,084 | 8.45% |
| 31 Mar, 23 | 29,111,980 | -0.88% |
| 31 Dec, 22 | 29,369,373 | -2.42% |
| 30 Sep, 22 | 30,096,390 | -0.35% |
| 30 Jun, 22 | 30,201,707 | -0.79% |
| 31 Mar, 22 | 30,440,812 | 2.01% |
| 31 Dec, 21 | 29,839,635 | 34.85% |
| 30 Sep, 21 | 22,128,223 | 6.70% |
| 30 Jun, 21 | 20,739,080 | 6.68% |
| 31 Mar, 21 | 19,439,693 | 152.35% |
| 31 Dec, 20 | 7,703,461 | - |
EyePoint Pharmaceuticals (EYPT) has 58.40M shares outstanding as of 30 Jun 24, up 6.20% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 110.38% | 1.02% |
| 31 Mar, 24 | 103.93% | 0.75% |
| 31 Dec, 23 | 117.49% | 1.52% |
| 30 Sep, 23 | 87.89% | 1.24% |
| 30 Jun, 23 | 84.02% | 1.39% |
| 31 Mar, 23 | 77.66% | 1.25% |
| 31 Dec, 22 | 78.70% | 1.21% |
| 30 Sep, 22 | 80.61% | 1.23% |
| 30 Jun, 22 | 80.92% | 1.21% |
| 31 Mar, 22 | 81.71% | 0.76% |
| 31 Dec, 21 | 103.76% | 1.75% |
| 30 Sep, 21 | 76.92% | 1.46% |
| 30 Jun, 21 | 72.51% | 1.17% |
| 31 Mar, 21 | 78.59% | 2.78% |
| 31 Dec, 20 | 53.12% | - |
As of 30 Jun 24, EyePoint Pharmaceuticals is held by 110.38% institutional shareholders, representing a 1.02% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 92 | -21.37% |
| 31 Mar, 24 | 117 | 25.81% |
| 31 Dec, 23 | 93 | 45.31% |
| 30 Sep, 23 | 64 | 33.33% |
| 30 Jun, 23 | 48 | 71.43% |
| 31 Mar, 23 | 28 | -30.00% |
| 31 Dec, 22 | 40 | 8.11% |
| 30 Sep, 22 | 37 | -5.13% |
| 30 Jun, 22 | 39 | - |
| 31 Mar, 22 | 39 | -40.00% |
| 31 Dec, 21 | 65 | 103.13% |
| 30 Sep, 21 | 32 | -13.51% |
| 30 Jun, 21 | 37 | -21.28% |
| 31 Mar, 21 | 47 | 42.42% |
| 31 Dec, 20 | 33 | - |
92 institutional shareholders have increased their position in EYPT stock as of 30 Jun 24 compared to 117 in the previous quarter (a -21.37% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 44 | 18.92% |
| 31 Mar, 24 | 37 | 5.71% |
| 31 Dec, 23 | 35 | 75.00% |
| 30 Sep, 23 | 20 | -4.76% |
| 30 Jun, 23 | 21 | 5.00% |
| 31 Mar, 23 | 20 | 5.26% |
| 31 Dec, 22 | 19 | -20.83% |
| 30 Sep, 22 | 24 | -4.00% |
| 30 Jun, 22 | 25 | -3.85% |
| 31 Mar, 22 | 26 | 85.71% |
| 31 Dec, 21 | 14 | -26.32% |
| 30 Sep, 21 | 19 | 18.75% |
| 30 Jun, 21 | 16 | 220.00% |
| 31 Mar, 21 | 5 | - |
| 31 Dec, 20 | - | - |
44 institutional shareholders have reduced their position in EYPT stock as of 30 Jun 24 compared to 37 in the previous quarter (a 18.92% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 157 | -10.29% | 58,402,790 | 6.20% | 110.38% | 1.02% | 92 | -21.37% | 44 | 18.92% |
| 31 Mar, 24 | 175 | 12.90% | 54,991,981 | 11.00% | 103.93% | 0.75% | 117 | 25.81% | 37 | 5.71% |
| 31 Dec, 23 | 155 | 42.20% | 49,541,998 | 47.02% | 117.49% | 1.52% | 93 | 45.31% | 35 | 75.00% |
| 30 Sep, 23 | 109 | 26.74% | 33,696,819 | 6.73% | 87.89% | 1.24% | 64 | 33.33% | 20 | -4.76% |
| 30 Jun, 23 | 86 | 22.86% | 31,573,084 | 8.45% | 84.02% | 1.39% | 48 | 71.43% | 21 | 5.00% |
| 31 Mar, 23 | 70 | -9.09% | 29,111,980 | -0.88% | 77.66% | 1.25% | 28 | -30.00% | 20 | 5.26% |
| 31 Dec, 22 | 77 | -10.47% | 29,369,373 | -2.42% | 78.70% | 1.21% | 40 | 8.11% | 19 | -20.83% |
| 30 Sep, 22 | 86 | 4.88% | 30,096,390 | -0.35% | 80.61% | 1.23% | 37 | -5.13% | 24 | -4.00% |
| 30 Jun, 22 | 82 | -3.53% | 30,201,707 | -0.79% | 80.92% | 1.21% | 39 | - | 25 | -3.85% |
| 31 Mar, 22 | 85 | -7.61% | 30,440,812 | 2.01% | 81.71% | 0.76% | 39 | -40.00% | 26 | 85.71% |
| 31 Dec, 21 | 92 | 35.29% | 29,839,635 | 34.85% | 103.76% | 1.75% | 65 | 103.13% | 14 | -26.32% |
| 30 Sep, 21 | 68 | 4.62% | 22,128,223 | 6.70% | 76.92% | 1.46% | 32 | -13.51% | 19 | 18.75% |
| 30 Jun, 21 | 65 | 3.17% | 20,739,080 | 6.68% | 72.51% | 1.17% | 37 | -21.28% | 16 | 220.00% |
| 31 Mar, 21 | 63 | 90.91% | 19,439,693 | 152.35% | 78.59% | 2.78% | 47 | 42.42% | 5 | - |
| 31 Dec, 20 | 33 | - | 7,703,461 | - | 53.12% | - | 33 | - | - | - |
EyePoint Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of EyePoint Pharmaceuticals's stock was made by Lurker Nancy on Jul 26 2024, selling 56,350 shares at $3.26 per share (valued at $183.70K).
EyePoint Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 10 | 12 | 83.33% |
| Q2 2024 | 10 | 9 | 111.11% |
| Q1 2024 | 70 | 88 | 79.55% |
| Q4 2023 | 31 | 21 | 147.62% |
| Q3 2023 | 5 | 19 | 26.32% |
| Q2 2023 | 30 | 9 | 333.33% |
| Q1 2023 | 20 | 20 | 100.00% |
| Q4 2022 | 1 | 2 | 50.00% |
| Q3 2022 | 5 | - | - |
| Q2 2022 | 1 | - | - |
| Q1 2022 | 33 | 18 | 183.33% |
| Q4 2021 | 4 | 9 | 44.44% |
| Q2 2021 | 21 | 3 | 700.00% |
| Q1 2021 | 9 | 11 | 81.82% |
| Q4 2020 | - | 1 | - |
| Q3 2020 | 2 | - | - |
| Q2 2020 | 11 | 15 | 73.33% |
| Q1 2020 | 26 | 1 | 2600.00% |
| Q4 2019 | 3 | 3 | 100.00% |
| Q3 2019 | 2 | 1 | 200.00% |
10 total buy trades, and 12 total sell trades (buy/sell ratio of 0.83%) were made by EyePoint Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | 4 | 2 | 200.00% |
| Q1 2024 | 2 | 25 | 8.00% |
| Q4 2023 | 18 | 10 | 180.00% |
| Q3 2023 | - | 18 | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 1 | - | - |
| Q4 2021 | - | 1 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 2 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | 2 | - | - |
| Q4 2019 | 1 | - | - |
| Q3 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of EyePoint Pharmaceuticals's stocks.
EyePoint Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. |
| BMEA | Biomea Fusion, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| OBIO | Orchestra BioMed Holdings, Inc. |
| OCUP | Ocuphire Pharma, Inc. |
| ALXO | ALX Oncology Holdings Inc. |
| VIRX | Viracta Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| CABA | Cabaletta Bio, Inc. |
| IPHA | Innate Pharma S.A. |
| HCWB | HCW Biologics Inc. |
| SLS | SELLAS Life Sciences Group, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| CMRX | Chimerix, Inc. |
EYPT Ownership FAQ
Who Owns EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals is owned by institutional shareholders (110.38%), insiders (1.42%), and public (-11.79%). The largest institutional shareholder of EyePoint Pharmaceuticals is CORMORANT ASSET MANAGEMENT, LP (15.73% of total shares) and the top mutual fund owner is FRANKLIN STRATEGIC SERIES (0.70% of total shares).
Who are the major institutional shareholders of EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals's major institutional shareholders are CORMORANT ASSET MANAGEMENT, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, BLACKROCK INC., FRANKLIN RESOURCES INC, and ADAGE CAPITAL PARTNERS GP, L.L.C.. The top five shareholders own together 46.32% of the company's share outstanding.
How many EyePoint Pharmaceuticals shareholders are there?
As of Jun 2024, there are 157 institutional shareholders of EyePoint Pharmaceuticals.
What percentage of EyePoint Pharmaceuticals is owned by CORMORANT ASSET MANAGEMENT, LP?
CORMORANT ASSET MANAGEMENT, LP owns 8.32M shares of EyePoint Pharmaceuticals, representing 15.73% of the company's total shares outstanding, valued at $72.43M (as of Jun 2024).
What percentage of EyePoint Pharmaceuticals is owned by SUVRETTA CAPITAL MANAGEMENT, LLC?
As of Jun 2024, SUVRETTA CAPITAL MANAGEMENT, LLC holds 5.18M shares of EyePoint Pharmaceuticals (EYPT), compromising 9.78% of the company, valued at $45.03M.
What percentage of EyePoint Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of EyePoint Pharmaceuticals. The company owns 3.76M of the company's shares outstanding (worth $32.75M).